​

Progyny (PGNY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PGNY Stock Forecast

Progyny (PGNY) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $28.50, with a high of $30.00 and a low of $27.00. This represents a 9.53% increase from the last price of $26.02.

$15 $20 $25 $30 $35 $40 High: $30 Avg: $28.5 Low: $27 Last Closed Price: $26.02

PGNY Stock Rating

Progyny stock's rating consensus is Buy, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (63.16%), 7 Hold (36.84%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 19 7 12 0 Strong Sell Sell Hold Buy Strong Buy

PGNY Price Target Upside V Benchmarks

TypeNameUpside
StockProgyny9.53%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 23.76%

Price Target Trends

1M3M12M
# Anlaysts125
Avg Price Target$29.00$29.50$27.40
Last Closing Price$26.02$26.02$26.02
Upside/Downside11.45%13.37%5.30%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-64--10
Nov, 25-55--10
Oct, 25-55--10
Sep, 25-55--10
Aug, 25-55--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 08, 2025Peter WarendorfBarclays$29.00$24.7017.41%11.45%
Nov 11, 2025KeyBanc$30.00$23.8126.00%15.30%
Aug 08, 2025Sarah JamesRaymond James$28.00$22.2226.01%7.61%
Jul 17, 2025Jailendra SinghTruist Financial$27.00$23.0517.14%3.77%
Feb 28, 2025Canaccord Genuity$23.00$22.532.09%-11.61%
Nov 13, 2024Glen SantangeloJefferies$19.00$21.61-12.08%-26.98%
Nov 13, 2024Sarah JamesCantor Fitzgerald$22.00$21.611.80%-15.45%
Nov 13, 2024Jailendra SinghTruist Financial$19.00$21.61-12.08%-26.98%
Sep 20, 2024Richard CloseCanaccord Genuity$18.00$16.469.36%-30.82%
Sep 20, 2024Michael ChernyBank of America Securities$22.00$16.4633.66%-15.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 08, 2025BarclaysOverweightinitialise
Nov 11, 2025KeyBancSector WeightOverweightupgrade
Aug 08, 2025Cantor FitzgeraldOverweightOverweighthold
Nov 13, 2024JefferiesBuyBuyhold
Nov 13, 2024Cantor FitzgeraldOverweightOverweighthold
Sep 20, 2024Truist FinancialMarket PerformMarket Performhold
Sep 20, 2024Canaccord GenuityHoldHoldhold
Sep 20, 2024Bank of America SecuritiesBuyBuyhold
Sep 19, 2024JefferiesBuyBuyhold
Sep 19, 2024JMP SecuritiesUnderperformMarket Performdowngrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.54$0.74$0.33$0.65$0.59----
Avg Forecast$0.18$0.54$0.28$0.59$0.54$0.60$0.90$1.26$1.41
High Forecast$0.19$0.57$0.29$0.61$0.55$0.68$1.27$1.44$1.45
Low Forecast$0.17$0.51$0.27$0.58$0.53$0.52$0.63$1.11$1.36
Surprise %200.00%37.04%17.86%10.17%9.26%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$344.86M$500.62M$786.91M$1.09B$1.17B----
Avg Forecast$342.45M$507.85M$784.27M$1.09B$1.14B$1.16B$1.29B$1.46B$1.65B
High Forecast$359.54M$533.20M$799.56M$1.10B$1.17B$1.18B$1.30B$1.46B$1.69B
Low Forecast$327.47M$485.64M$764.43M$1.06B$1.13B$1.14B$1.29B$1.46B$1.61B
Surprise %0.70%-1.42%0.34%-0.38%1.98%----

Net Income Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$46.46M$65.77M$30.36M$62.04M$54.34M----
Avg Forecast$71.52M$54.03M$108.97M$62.04M$54.38M$60.07M$77.16M$128.36M$141.44M
High Forecast$86.79M$57.53M$130.76M$74.44M$55.77M$68.28M$128.28M$144.97M$145.51M
Low Forecast$56.25M$50.96M$87.17M$49.63M$53.00M$51.86M$63.12M$111.75M$136.60M
Surprise %-35.04%21.73%-72.14%--0.08%----

PGNY Forecast FAQ

Is Progyny stock a buy?

Progyny stock has a consensus rating of Buy, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Progyny is a favorable investment for most analysts.

What is Progyny's price target?

Progyny's price target, set by 19 Wall Street analysts, averages $28.5 over the next 12 months. The price target range spans from $27 at the low end to $30 at the high end, suggesting a potential 9.53% change from the previous closing price of $26.02.

How does Progyny stock forecast compare to its benchmarks?

Progyny's stock forecast shows a 9.53% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare information services stocks industry (23.76%).

What is the breakdown of analyst ratings for Progyny over the past three months?

  • December 2025: 0% Strong Buy, 60.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Progyny’s EPS forecast?

Progyny's average annual EPS forecast for its fiscal year ending in December 2025 is $0.6, marking a 1.69% increase from the reported $0.59 in 2024. Estimates for the following years are $0.9 in 2026, $1.26 in 2027, and $1.41 in 2028.

What is Progyny’s revenue forecast?

Progyny's average annual revenue forecast for its fiscal year ending in December 2025 is $1.16B, reflecting a -0.71% decrease from the reported $1.17B in 2024. The forecast for 2026 is $1.29B, followed by $1.46B for 2027, and $1.65B for 2028.

What is Progyny’s net income forecast?

Progyny's net income forecast for the fiscal year ending in December 2025 stands at $60.07M, representing an 10.55% increase from the reported $54.34M in 2024. Projections indicate $77.16M in 2026, $128.36M in 2027, and $141.44M in 2028.